LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 162 filers reported holding LEGEND BIOTECH CORP in Q3 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,683,604 | -1.8% | 278,154 | +0.9% | 0.30% | +10.7% |
| Q2 2023 | $19,035,299 | -22.2% | 275,754 | -45.6% | 0.27% | -23.4% |
| Q1 2023 | $24,459,788 | +38.1% | 507,254 | +43.0% | 0.36% | +51.1% |
| Q4 2022 | $17,711,067 | -30.6% | 354,789 | -43.3% | 0.24% | -35.8% |
| Q3 2022 | $25,519,000 | -26.4% | 625,461 | -0.8% | 0.37% | -25.3% |
| Q2 2022 | $34,674,000 | +44.6% | 630,439 | -4.5% | 0.49% | +75.6% |
| Q1 2022 | $23,987,000 | -21.7% | 660,069 | +0.4% | 0.28% | -11.7% |
| Q4 2021 | $30,653,000 | +111.6% | 657,656 | +129.5% | 0.32% | +115.0% |
| Q3 2021 | $14,488,000 | -9.5% | 286,556 | -26.6% | 0.15% | -5.8% |
| Q2 2021 | $16,016,000 | -8.5% | 390,163 | -35.3% | 0.16% | -15.7% |
| Q1 2021 | $17,506,000 | +49.3% | 603,243 | +44.9% | 0.18% | +38.1% |
| Q4 2020 | $11,724,000 | +105.2% | 416,341 | +210.1% | 0.13% | +65.4% |
| Q2 2020 | $5,714,000 | – | 134,261 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |